Paravertebral Catheters for VATS Procedures

• Status: Completed
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Level I randomized prospective outcomes study comparing two groups of patients. One group will receive Dilaudid patient controlled analgesia (PCA) post-operatively. The other will receive an ultrasound guided paravertebral block with indwelling paravertebral catheter with an infusion of 0.2% Ropivicaine post-operatively and a PCA.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Minnesota; University of Minnesota - Clinical and Translational Science Institute
• Treatments: Analgesics, Opioid; Ropivacaine

Criteria

Inclusion Criteria:

• • All patients undergoing elective VATS.

Exclusion Criteria:

• • Previous difficult airway or multiple previous intubations

• History of myasthenic syndrome

• Systemic infection

• Pre-existing sensory deficit

• PT >14 or PTT >40 sec

• Platelet count less than 50,000

• Creatinine > 1.5

• Allergy to local anesthetics

• Patients who remain intubated for one week after surgery or who are unable to provide information as to their feelings of pain post-operatively for the first week post-operatively

• Use of a spinal or epidural anesthetic for surgery

• Daily use of opioid for more than a week

• Lack of patient cooperation

• Contraindication to regional anesthesia

• Infection at injection site

• Inability to guarantee sterile equipment or sterile conditions for the block

• Patient refusal

• Risk of local anesthetic toxicity

• Coagulopathy or bleeding disorder

• Severe respiratory disease (where the patient depends on intercostal muscle function for ventilation);

• Ipsilateral diaphragmatic paresis;

• Severe spinal deformities (kyphosis or scoliosis)

• Previous thoracotomy